|
|
|
|
| LEADER |
11342nam a22004933i 4500 |
| 001 |
EBC5997173 |
| 003 |
MiAaPQ |
| 005 |
20210318061024.0 |
| 006 |
m o d | |
| 007 |
cr cnu|||||||| |
| 008 |
210318s2020 xx o ||||0 eng d |
| 020 |
|
|
|a 9781536166149
|q (electronic bk.)
|
| 020 |
|
|
|z 9781536166132
|
| 035 |
|
|
|a (MiAaPQ)EBC5997173
|
| 035 |
|
|
|a (Au-PeEL)EBL5997173
|
| 035 |
|
|
|a (OCoLC)1134076394
|
| 040 |
|
|
|a MiAaPQ
|b eng
|e rda
|e pn
|c MiAaPQ
|d MiAaPQ
|
| 050 |
|
4 |
|a RC388.5
|b .E535 2019
|
| 082 |
0 |
|
|a 616.80999999999995
|
| 100 |
1 |
|
|a Townsend, Sean M.
|
| 245 |
1 |
0 |
|a Encyclopedia of Stroke (9 Volume Set).
|
| 264 |
|
1 |
|a New York :
|b Nova Science Publishers, Incorporated,
|c 2020.
|
| 264 |
|
4 |
|c ©2019.
|
| 300 |
|
|
|a 1 online resource (2388 pages)
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 490 |
1 |
|
|a New Developments in Medical Research Ser.
|
| 505 |
0 |
|
|a Intro -- Contents -- Preface -- Chapter 1 -- Management of Carotid Stenosis: Carotid Revascularization in the Modern Era -- Abstract -- Atherosclerosis: The Role of Inflammation -- Evolution of Carotid Revascularization -- The North American Symptomatic Carotid Endarterectomy Trial (NASCET) -- Ideal Timing for Revascularization Procedures -- The Asymptomatic Carotid Artery Surgery Trial (ACAS) -- The Asymptomatic Carotid Surgery Trial (ACST-1) -- Stenting and Angioplasty with Protection in Patients at High Risk for Endarterectomy Trial (SAPPHIRE) -- The Carotid Revascularization Endarterectomy versus Stenting Trial (CREST) -- Carotid Revascularization in Asymptomatic Patients -- Carotid Revascularization in the Elderly -- Carotid Revascularization in Women -- Physician Specialty and the Choice of Revascularization Procedure -- Carotid CAS Complication Rates over Time -- Making the Case for Intensive Medical Therapy for Asymptomatic Carotid Stenosis -- Future Directions -- References -- Chapter 2 -- Ischemic Stroke: From Acute Treatment to Long-Term Recovery -- Abstract -- Introduction -- Acute Ischemic Stroke Treatment -- Future Directions and Conclusion -- Stroke Prevention: Managing Modifiable Risk Factors -- Treatment of Hypertension -- Atrial Fibrillation -- Treating Hyperlipidemia -- Diabetes -- Antiplatelet Therapy -- Cilostazol in the Management of Atherosclerosis -- Stroke Rehabilitation -- Neuroplasticity and Mechanisms of Recovery -- References -- Chapter 3 -- Ischemic Stroke Prevention in Vietnam -- Abstract -- Introduction -- Stroke Prevalence and Incidence -- Morbidity and Mortality Trend -- Risk Factors of Stroke -- Non-Modifiable Risk Factors -- Modifiable Risk Factors -- Prevention Strategy in Vietnam -- Conclusion -- References -- Chapter 4.
|
| 505 |
8 |
|
|a Modulation of Protein Kinase C Isoforms: A Potential Therapeutic for Ischemic Stroke? -- Abstract -- Introduction -- PKC Isoforms - A Lesson in Structure-Function Relationships -- Expression of PKC Isoforms - Systemic and Cellular Considerations -- Activation of PKC Isoforms -- Regulating PKC Activation -- PKC - A Role in Disease Processes? -- Effect of Neural Disease and Injury on Pkc Activity -- Alzheimer's Disease (AD) -- Ischemia -- Ischemic Preconditioning -- Traumatic Brain Injury -- Role of Pkc in Neural Injury Outcome -- Modulation of Response to Oxidative Stress -- Effect of PKC on Cell Survival -- Regulating BBB Integrity Through Matrix Remodeling -- Role in Recovery and Repair Following Neural Injury -- Effect of PKC Modulation on Learning and Memory -- Studying Pkc Isoform-Specific Events: Using Available Tools -- Future Directions -- Alterations in PKC-Mediated Signaling Associated with Aging -- Elucidating Cell-Specific and Time-Dependent Events -- Understanding PKC-Mediated Pathways -- Conclusion -- References -- Chapter 5 -- Role of Transcranial Doppler Ultrasonography in Cerebrovascular Disease -- Abstract -- Introduction -- Fast Track Insonation Protocol -- Prolonged TCD Monitoring -- Therapeutic TCD -- Ultrasound Contrast Agents and Sonothrombolysis -- TCD in Cartoid Stenosis and Endarterectomy -- TCD in Intracranial Stenosis -- Vasomotor Reactivity -- Right-to-Left Shunt Detection -- Use of TCD in Sickle Cell Disease -- TCD for Vasospasm Studies in Subarachnoid Hemorrhage (SAH) -- Transcranial Color-Coded Duplex (TCCD) -- Future Developments -- References -- Chapter 6 -- Inflammation in Ischemic Stroke: Mechanisms, Diagnosis and Management -- Abstract -- I. Introduction -- II. Pathophysiology -- a. Cytokines -- b. Microglia -- c. T Cells -- III. Diagnostic Imaging -- a. Computed Tomography (CT).
|
| 505 |
8 |
|
|a b. Magnetic Resonance Imaging (MRI) -- c. Ultrasound -- d. Single Photon Emission Computed Tomography (SPECT) -- e. Near-Infrared Fluorescence (NIRF) -- IV. Prevention and Treatment -- a. Prevention -- b. Treatment -- b1. Currently Available Therapies -- b2. Novel Therapies -- Pharmacologically Induced Hypothermia -- Erythropoietin -- Other Neuroprotective Agents -- Cell-Based Therapies -- Summary and Conclusion -- References -- Chapter 7 -- Ischemic Stroke Susceptibility Gene Research: Lessons We Learned -- Abstract -- Overview of Strokes -- Stratification of Ischemic Stroke -- Risk Factors for Stroke -- Monogenic Disorders Associated with Ischemic Stroke -- Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leucoenchephalopathy (CADASIL) -- Cerebral Autosomal-Recessive Arteriopathy with Subcortical Infarcts and Leukoenchephalopathy (CARASIL) -- Fabry's Disease -- Sickle-Cell Disease -- Mitochondrial Myopathy, Encephalopathy, Lactic Acidosis, and Stroke-Like Episodes (MELAS) -- Homocystinuria -- Moyamoya Disease -- Marfan's Syndrome -- Ehlers-Danlos Syndrome -- Periods in the Stroke Susceptibility Research -- The Classic Genetic Risk Factors and the Stroke -- Further Search for the Functional SNPs in Stroke -- Direct Genome-Wide Association Studies in Ischemic Stroke Biobanks -- Concluding Remarks -- Acknowledgments -- References -- Chapter 8 -- Perioperative Ischemic Stroke -- Abstract -- Introduction -- Epidemiology -- Pathogenic Mechanism -- Prognosis -- Risk Factors -- 1) Patient Factors -- Age and Co-morbiditiy -- History of Stroke -- Carotid Stenosis -- 2) Surgery Factors -- Blood Pressure Control -- Anesthesia -- Cardiac Surgery -- Perioperative Drug Use -- Anti-platelet Agents or Anti-coagulants -- Statins -- Beta-Blockers -- Risk Stratification -- Treatment -- Conclusion -- References -- Chapter 9.
|
| 505 |
8 |
|
|a Traditional Medicine in the Treatment and Prevention of Ischemic Stroke -- Abstract -- Abbreviations Used -- Introduction -- Traditional Medicine - An Overview -- Traditional African Medicine (TAM) -- Traditional Chinese Medicine (TCM) -- Stroke -- Cerebral Ischemia - Pathophysiology and Mechanisms -- Yin-Yang Theory in TCM -- Basic Principles of Stroke in TCM -- Traditional Chinese Medicine and Stroke Therapy -- Herbs Used for Treatment or Prevention of Stroke in TCM -- Acanthropanax Senticosus Harms -- Angelica Sinensis, A. Gigas -- Astragalus Membranaceus -- Bombycis Corpus -- Carthamus Tinctorius -- Corydalis Yanhusuo -- Ginkgo Biloba -- Ligusticum Wallichii Franchat -- Lycium Barbaarum L. -- Magnolia Officinalis Rehder Et Wilson -- Paeonia Suffruticosa Andrews, Paeonia Lactiflora Pall -- Panax Ginseng -- Pueraria Lobata -- Rhodiola Rosea L., Rhodiola Sacra S. H. FU, Rhodiola Sachalinensis A. BOR -- Salvia Miltiorrhiza Bunge -- Schisandra Chinensis -- Scutellaria Baicalensis -- Sophora Japonica L. -- Stephania Tetrandra S. Moore -- Herbal Prescriptions in TCM -- Buyang Huanwu Decoction (BYHWD) 五汤 -- Buchang Naoxintong Jiaonang (BNJ) 步 心 囊 -- Danqi Piantang Jiaonang (DJ) 丹 偏 囊 -- Huang Lian Jie Du Decoction (HHD) 毒汤 -- Kueichih Fuling Wan (KFW) 桂枝 丸 -- Qingkailing (QKL) Injection 清开灵注射液 -- Qizhu Tang Decoction (QZT) 术汤 -- Shengmai San 生 散 -- Acupuncture -- Traditional Chinese Medicine - Weakness -- Traditional Chinese Medicine - Future Developments -- Conclusion -- References -- Chapter 10 -- Ischemic Stroke in Children: Symptoms, Prevention and Recovery -- Abstract -- Introduction -- Arterial Ischemic Stroke -- Clinical Presentation -- Etiologies and Risk Factors -- Cardiac Disease or Intervention -- Cerebral Arteriopathies -- Prothrombotic and Hematological Disorders -- Genetic and Other Risk Factors.
|
| 505 |
8 |
|
|a Risk Factors for Ischemic Perinatal Stroke -- Treatment and Prevention of Childhood AIS -- General Treatment of AIS -- Acute Treatment -- Hyperacute Thrombolytic Therapy -- Acute Antithrombotic Therapy -- Supportive Therapy -- Long Term Therapy -- Secondary Prevention -- Rehabilitative Approaches -- Treatment of Specific Etiological Disorders Associated with Ischemic Stroke -- Recovery and Outcome -- Cerebral Sinovenous Thrombosis -- Clinical Presentation -- Etiologies and Risk Factors -- Clinical Diagnosis -- Treatment -- Future Directions -- References -- Chapter 11 -- The Immune System and Strokes -- Abstract -- Introduction -- Cells of the Immune System -- Role of Inflammation and the Immune System in Stroke -- Immune System-Brain Interactions in the Acute Phase of a Stroke -- Natural Regulatory T Cells -- Targets for Stroke Prevention: Role of Inflammation and Immunity -- Immunomodulation to Restrict Brain-Tissue Damage after a Stroke -- Difficulties in Translation from Bench to Bedside and Research Priorities -- Modulation of the Post-Ischemic Immune Response to Improve the Stroke Outcome -- References -- Chapter 12 -- Pathophysiology of Strokes -- Abstract -- Introduction -- Mechanisms of Neuronal Injury -- Concept of Ischemic Penumbra -- Cerebral Edema and Its Effects -- Effects of Ischemia on Structural Integrity of Brain -- Hemorrhagic Stroke -- Atherosclerosis and Stroke -- Free Radicals in Cerebral Damage -- Excitotoxicity -- Cortical Spreading Depolarizations -- Inflammation -- Inflammation and Stroke -- Infective Conditions Associated with Stroke -- Inflammatory Mediators in Acute Stroke -- Inflammatory Gene Expression -- Cytokines -- Chemokines -- Matrix Metalloproteinases (MMPs) -- Adhesion Molecules -- Neuropeptides -- Cellular Arm -- Leukocytes -- Microglia -- Acute Phase Reactants and Body Temperature -- C-reactive Protein.
|
| 505 |
8 |
|
|a Erythrocyte Sedimentation Rate And Fibrinogen (ESR).
|
| 526 |
0 |
|
|a HS115 - Diploma in Occupational Therapy (OT)
|z Syllabus Programme
|
| 588 |
|
|
|a Description based on publisher supplied metadata and other sources.
|
| 590 |
|
|
|a Electronic reproduction. Ann Arbor, Michigan : ProQuest Ebook Central, 2021. Available via World Wide Web. Access may be limited to ProQuest Ebook Central affiliated libraries.
|
| 650 |
|
0 |
|a Cerebrovascular disease-Encyclopedias.
|
| 655 |
|
4 |
|a Electronic books.
|
| 776 |
0 |
8 |
|i Print version:
|a Townsend, Sean M.
|t Encyclopedia of Stroke (9 Volume Set)
|d New York : Nova Science Publishers, Incorporated,c2020
|z 9781536166132
|
| 797 |
2 |
|
|a ProQuest (Firm)
|
| 830 |
|
0 |
|a New Developments in Medical Research Ser.
|
| 856 |
4 |
0 |
|u https://ezaccess.library.uitm.edu.my/login?url=https://ebookcentral.proquest.com/lib/uitm-ebooks/detail.action?docID=5997173
|z View fulltext via EzAccess
|
| 966 |
0 |
|
|a 2021
|b ProQuest Ebook Central
|c UiTM Library
|d Dr. Wan Ismahanisa Ismail
|e Faculty of Health Sciences
|f ProQuest
|